

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 5.26035300 |
| 2 | heterochromatin organization (GO:0070828) | 4.64706684 |
| 3 | protein localization to kinetochore (GO:0034501) | 4.38556295 |
| 4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.26582583 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.22895444 |
| 6 | regulation of translational fidelity (GO:0006450) | 3.98994714 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 3.95805496 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.95805496 |
| 9 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.93063770 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76089246 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68901124 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66658432 |
| 13 | protein localization to chromosome, centromeric region (GO:0071459) | 3.65192674 |
| 14 | mitotic nuclear envelope disassembly (GO:0007077) | 3.64901508 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 3.64774938 |
| 16 | viral transcription (GO:0019083) | 3.62818580 |
| 17 | negative regulation of RNA splicing (GO:0033119) | 3.57404612 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.57265303 |
| 19 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.55784302 |
| 20 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.55784302 |
| 21 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.50775165 |
| 22 | nuclear pore organization (GO:0006999) | 3.49928904 |
| 23 | sister chromatid segregation (GO:0000819) | 3.49749961 |
| 24 | dosage compensation (GO:0007549) | 3.48719381 |
| 25 | regulation of translational termination (GO:0006449) | 3.48233791 |
| 26 | translational termination (GO:0006415) | 3.48204562 |
| 27 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.46358411 |
| 28 | membrane disassembly (GO:0030397) | 3.45102257 |
| 29 | nuclear envelope disassembly (GO:0051081) | 3.45102257 |
| 30 | nuclear pore complex assembly (GO:0051292) | 3.43065146 |
| 31 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.43058787 |
| 32 | mitotic sister chromatid segregation (GO:0000070) | 3.43046857 |
| 33 | mRNA stabilization (GO:0048255) | 3.42111698 |
| 34 | RNA stabilization (GO:0043489) | 3.42111698 |
| 35 | modulation by virus of host process (GO:0019054) | 3.39665534 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39256248 |
| 37 | pinocytosis (GO:0006907) | 3.39195322 |
| 38 | mitotic chromosome condensation (GO:0007076) | 3.39063602 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.36539209 |
| 40 | DNA strand elongation (GO:0022616) | 3.34935589 |
| 41 | DNA replication initiation (GO:0006270) | 3.34006775 |
| 42 | maternal placenta development (GO:0001893) | 3.33877755 |
| 43 | DNA duplex unwinding (GO:0032508) | 3.33005666 |
| 44 | chromatin assembly (GO:0031497) | 3.32556112 |
| 45 | barbed-end actin filament capping (GO:0051016) | 3.31907701 |
| 46 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.30731708 |
| 47 | modulation by symbiont of host cellular process (GO:0044068) | 3.30107904 |
| 48 | DNA geometric change (GO:0032392) | 3.28839474 |
| 49 | pre-miRNA processing (GO:0031054) | 3.27553874 |
| 50 | translational elongation (GO:0006414) | 3.25767872 |
| 51 | negative regulation of mRNA processing (GO:0050686) | 3.23978083 |
| 52 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.21644063 |
| 53 | peptidyl-lysine dimethylation (GO:0018027) | 3.21100673 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17199202 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16972877 |
| 56 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.16373517 |
| 57 | negative regulation of histone methylation (GO:0031061) | 3.16373022 |
| 58 | pentose-phosphate shunt (GO:0006098) | 3.16127285 |
| 59 | protein retention in ER lumen (GO:0006621) | 3.15326847 |
| 60 | proline biosynthetic process (GO:0006561) | 3.13322091 |
| 61 | formation of translation preinitiation complex (GO:0001731) | 3.10650134 |
| 62 | ribosomal small subunit assembly (GO:0000028) | 3.09812886 |
| 63 | GDP-mannose metabolic process (GO:0019673) | 3.09491783 |
| 64 | T cell apoptotic process (GO:0070231) | 3.06546743 |
| 65 | regulation of protein heterodimerization activity (GO:0043497) | 3.06342890 |
| 66 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.03663857 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.03521864 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.03521864 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 3.03521864 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 3.03521864 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.03521864 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.03521864 |
| 73 | positive regulation of histone deacetylation (GO:0031065) | 3.03219862 |
| 74 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.02824101 |
| 75 | translational initiation (GO:0006413) | 3.01775675 |
| 76 | regulation of sister chromatid cohesion (GO:0007063) | 3.00719907 |
| 77 | glucose catabolic process (GO:0006007) | 2.99476908 |
| 78 | cellular response to virus (GO:0098586) | 2.99015360 |
| 79 | mature B cell differentiation involved in immune response (GO:0002313) | 2.98085236 |
| 80 | Peyers patch development (GO:0048541) | 2.97980416 |
| 81 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.97980416 |
| 82 | negative regulation of mRNA metabolic process (GO:1903312) | 2.97697459 |
| 83 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.96276180 |
| 84 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.95933135 |
| 85 | mitotic nuclear envelope reassembly (GO:0007084) | 2.95726429 |
| 86 | nuclear envelope reassembly (GO:0031468) | 2.95726429 |
| 87 | response to peptidoglycan (GO:0032494) | 2.94469404 |
| 88 | IMP biosynthetic process (GO:0006188) | 2.93808671 |
| 89 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.93029306 |
| 90 | regulation of defense response to virus by virus (GO:0050690) | 2.92765445 |
| 91 | regulation of histone H3-K9 methylation (GO:0051570) | 2.91879411 |
| 92 | translesion synthesis (GO:0019985) | 2.91509428 |
| 93 | nuclear envelope organization (GO:0006998) | 2.90186367 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.85401653 |
| 95 | response to UV-C (GO:0010225) | 2.83451939 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.80504564 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 2.80043797 |
| 98 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.79300538 |
| 99 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.79294256 |
| 100 | UV protection (GO:0009650) | 2.78652839 |
| 101 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.78424914 |
| 102 | negative regulation of cell size (GO:0045792) | 2.78409634 |
| 103 | regulation of monocyte differentiation (GO:0045655) | 2.77127272 |
| 104 | endothelial tube morphogenesis (GO:0061154) | 2.75514882 |
| 105 | morphogenesis of an endothelium (GO:0003159) | 2.75514882 |
| 106 | apoptotic process involved in morphogenesis (GO:0060561) | 2.74469755 |
| 107 | chromatin assembly or disassembly (GO:0006333) | 2.74141542 |
| 108 | activation of MAPKKK activity (GO:0000185) | 2.73382332 |
| 109 | regulation of gene silencing by RNA (GO:0060966) | 2.73285732 |
| 110 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.73285732 |
| 111 | regulation of gene silencing by miRNA (GO:0060964) | 2.73285732 |
| 112 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.72379160 |
| 113 | viral life cycle (GO:0019058) | 2.71164021 |
| 114 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.70559139 |
| 115 | protein complex disassembly (GO:0043241) | 2.69463923 |
| 116 | ribosomal small subunit biogenesis (GO:0042274) | 2.69073167 |
| 117 | mitotic G1/S transition checkpoint (GO:0044819) | 2.68615745 |
| 118 | histone H2A monoubiquitination (GO:0035518) | 2.68431312 |
| 119 | cellular protein complex disassembly (GO:0043624) | 2.67996401 |
| 120 | IMP metabolic process (GO:0046040) | 2.67845538 |
| 121 | regulation of hippo signaling (GO:0035330) | 2.67654808 |
| 122 | protein localization to chromosome (GO:0034502) | 2.66019759 |
| 123 | NADPH regeneration (GO:0006740) | 2.65975866 |
| 124 | paraxial mesoderm development (GO:0048339) | 2.65942617 |
| 125 | negative regulation of necroptotic process (GO:0060546) | 2.65115593 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64951263 |
| 127 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.63762752 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.63714117 |
| 129 | immunoglobulin mediated immune response (GO:0016064) | 2.62535734 |
| 130 | regulation of spindle organization (GO:0090224) | 2.62115782 |
| 131 | mitotic recombination (GO:0006312) | 2.61239108 |
| 132 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.60799313 |
| 133 | regulation of necrotic cell death (GO:0010939) | 2.60702972 |
| 134 | regulation of mRNA stability (GO:0043488) | 2.60092890 |
| 135 | protein maturation by protein folding (GO:0022417) | 2.59180780 |
| 136 | protein localization to endosome (GO:0036010) | 2.58940826 |
| 137 | leukocyte aggregation (GO:0070486) | 2.58829165 |
| 138 | positive regulation of chromosome segregation (GO:0051984) | 2.58171693 |
| 139 | DNA conformation change (GO:0071103) | 2.58066707 |
| 140 | maturation of SSU-rRNA (GO:0030490) | 2.57579058 |
| 141 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.56953270 |
| 142 | positive regulation of B cell differentiation (GO:0045579) | 2.56073363 |
| 143 | telomere maintenance via recombination (GO:0000722) | 2.54882459 |
| 144 | establishment of apical/basal cell polarity (GO:0035089) | 2.54821142 |
| 145 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.54647394 |
| 146 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.53219651 |
| 147 | lymphocyte apoptotic process (GO:0070227) | 2.53129877 |
| 148 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.52961717 |
| 149 | modulation by virus of host morphology or physiology (GO:0019048) | 2.51963166 |
| 150 | positive regulation of protein deacetylation (GO:0090312) | 2.51933187 |
| 151 | pore complex assembly (GO:0046931) | 2.49152970 |
| 152 | protein-DNA complex disassembly (GO:0032986) | 2.47520599 |
| 153 | nucleosome disassembly (GO:0006337) | 2.47520599 |
| 154 | protein targeting to ER (GO:0045047) | 2.47150852 |
| 155 | thymic T cell selection (GO:0045061) | 2.46848836 |
| 156 | regulation of RNA stability (GO:0043487) | 2.46255095 |
| 157 | cellular response to interleukin-4 (GO:0071353) | 2.45933105 |
| 158 | mannose metabolic process (GO:0006013) | 2.45337440 |
| 159 | chromosome condensation (GO:0030261) | 2.44912875 |
| 160 | regulation of mitotic spindle organization (GO:0060236) | 2.44055494 |
| 161 | regulation of necroptotic process (GO:0060544) | 2.42383536 |
| 162 | pentose metabolic process (GO:0019321) | 2.41581316 |
| 163 | embryonic process involved in female pregnancy (GO:0060136) | 2.40754070 |
| 164 | negative regulation of phagocytosis (GO:0050765) | 2.40039468 |
| 165 | virion assembly (GO:0019068) | 2.39523794 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.39101592 |
| 167 | regulation of early endosome to late endosome transport (GO:2000641) | 2.38313726 |
| 168 | glucose 6-phosphate metabolic process (GO:0051156) | 2.38025052 |
| 169 | stress fiber assembly (GO:0043149) | 2.34875997 |
| 170 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34812360 |
| 171 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.33965931 |
| 172 | negative regulation of cell killing (GO:0031342) | 2.33965931 |
| 173 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33737701 |
| 174 | cellular hyperosmotic response (GO:0071474) | 2.33073827 |
| 175 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.31161691 |
| 176 | negative regulation of B cell apoptotic process (GO:0002903) | 2.28819281 |
| 177 | regulation of mast cell degranulation (GO:0043304) | 2.27538424 |
| 178 | actin nucleation (GO:0045010) | 2.27183676 |
| 179 | response to interleukin-4 (GO:0070670) | 2.25534832 |
| 180 | regulation of gamma-delta T cell activation (GO:0046643) | 2.25271553 |
| 181 | detection of bacterium (GO:0016045) | 2.24836016 |
| 182 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.24796218 |
| 183 | post-embryonic morphogenesis (GO:0009886) | 2.24693552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.34293720 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.36596021 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.45922049 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31277366 |
| 5 | * MYC_22102868_ChIP-Seq_BL_Human | 3.22151864 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.78809588 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.70077996 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.64404935 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.59126417 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.42674282 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39907994 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.20327571 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00708518 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93916114 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92256644 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81430921 |
| 17 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78502260 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.75412652 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75101911 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.71716011 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68694994 |
| 22 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.63976219 |
| 23 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60615899 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.59553445 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56376231 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55481761 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53726229 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53160486 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52512928 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51068054 |
| 31 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.50893961 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49329898 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.48658702 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48312670 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46872852 |
| 36 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45026275 |
| 37 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45004151 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44017062 |
| 39 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43064760 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40632243 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39962404 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37970937 |
| 43 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37040918 |
| 44 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36541340 |
| 45 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.36180337 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35979274 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35967819 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35157183 |
| 49 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35014780 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34117013 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33704364 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.32954549 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31120784 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30552453 |
| 55 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29009337 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27339378 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26739558 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26472946 |
| 59 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24526026 |
| 60 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24284546 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23428085 |
| 62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21964438 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21397412 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21250375 |
| 65 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20386314 |
| 66 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19018911 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18926062 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18854440 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18349699 |
| 70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18057801 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17988930 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17155714 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17015193 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16639276 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16400699 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15670080 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15165440 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15052671 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14723086 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14490282 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13623447 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13598210 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13434425 |
| 84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12748252 |
| 85 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.12265187 |
| 86 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12117099 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11814956 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10738570 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10421709 |
| 90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09857679 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09559355 |
| 92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08083905 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07715513 |
| 94 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07659276 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07620252 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07144200 |
| 97 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.07129254 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 1.06622835 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06579441 |
| 100 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06564118 |
| 101 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.05918146 |
| 102 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05726566 |
| 103 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05569592 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05069300 |
| 105 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04669589 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03561539 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03276251 |
| 108 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02869217 |
| 109 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02477724 |
| 110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02382354 |
| 111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01622010 |
| 112 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.01354844 |
| 113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00835743 |
| 114 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00689016 |
| 115 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00551502 |
| 116 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99537760 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99384814 |
| 118 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99235354 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 0.98942579 |
| 120 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98637863 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98391300 |
| 122 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98115875 |
| 123 | * ZNF263_19887448_ChIP-Seq_K562_Human | 0.97852512 |
| 124 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97424636 |
| 125 | MYB_26560356_Chip-Seq_TH1_Human | 0.96416395 |
| 126 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.96400173 |
| 127 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96316139 |
| 128 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.95407642 |
| 129 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93246487 |
| 130 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92040665 |
| 131 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91393630 |
| 132 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91191516 |
| 133 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.90383049 |
| 134 | P68_20966046_ChIP-Seq_HELA_Human | 0.88778611 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.88741336 |
| 136 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88017730 |
| 137 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88008792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.85868798 |
| 2 | MP0005451_abnormal_body_composition | 3.43592679 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.33059579 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 3.09232919 |
| 5 | MP0003436_decreased_susceptibility_to | 2.88877758 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.84161207 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.71040057 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.66279412 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.52980220 |
| 10 | MP0008260_abnormal_autophagy | 2.52297993 |
| 11 | MP0003077_abnormal_cell_cycle | 2.52091331 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.38320800 |
| 13 | MP0010307_abnormal_tumor_latency | 2.18965501 |
| 14 | MP0009278_abnormal_bone_marrow | 2.14243380 |
| 15 | MP0001730_embryonic_growth_arrest | 2.09845004 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.01672596 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.00801497 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.00783376 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.98807096 |
| 20 | MP0000350_abnormal_cell_proliferation | 1.92895929 |
| 21 | MP0005025_abnormal_response_to | 1.90847574 |
| 22 | MP0004858_abnormal_nervous_system | 1.89678509 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.86424512 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.84984675 |
| 25 | MP0001849_ear_inflammation | 1.80137818 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.78090168 |
| 27 | MP0006054_spinal_hemorrhage | 1.75219793 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.74259995 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.73932678 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.71451643 |
| 31 | MP0004197_abnormal_fetal_growth/weight/ | 1.71039363 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.70775208 |
| 33 | MP0000733_abnormal_muscle_development | 1.69982949 |
| 34 | MP0002419_abnormal_innate_immunity | 1.69760152 |
| 35 | MP0003123_paternal_imprinting | 1.66236495 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.64204392 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.63075068 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.63075068 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.62807966 |
| 40 | MP0000490_abnormal_crypts_of | 1.62391781 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.59736102 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.59025691 |
| 43 | MP0001819_abnormal_immune_cell | 1.58033550 |
| 44 | MP0005023_abnormal_wound_healing | 1.56105134 |
| 45 | MP0001800_abnormal_humoral_immune | 1.55776549 |
| 46 | MP0001697_abnormal_embryo_size | 1.55076721 |
| 47 | MP0001672_abnormal_embryogenesis/_devel | 1.54596119 |
| 48 | MP0005380_embryogenesis_phenotype | 1.54596119 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 1.54464027 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.54022950 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.52593588 |
| 52 | MP0003984_embryonic_growth_retardation | 1.50751637 |
| 53 | MP0002723_abnormal_immune_serum | 1.50141811 |
| 54 | MP0002088_abnormal_embryonic_growth/wei | 1.49003971 |
| 55 | MP0002080_prenatal_lethality | 1.48362934 |
| 56 | MP0002084_abnormal_developmental_patter | 1.48261959 |
| 57 | MP0009053_abnormal_anal_canal | 1.46081083 |
| 58 | MP0002085_abnormal_embryonic_tissue | 1.45847664 |
| 59 | MP0001790_abnormal_immune_system | 1.44610758 |
| 60 | MP0005387_immune_system_phenotype | 1.44610758 |
| 61 | MP0003303_peritoneal_inflammation | 1.42454701 |
| 62 | MP0008057_abnormal_DNA_replication | 1.41058700 |
| 63 | MP0000716_abnormal_immune_system | 1.40842940 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.36333515 |
| 65 | MP0005671_abnormal_response_to | 1.35655325 |
| 66 | MP0003567_abnormal_fetal_cardiomyocyte | 1.33236346 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 1.32296644 |
| 68 | MP0001853_heart_inflammation | 1.31696110 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.30748464 |
| 70 | MP0003866_abnormal_defecation | 1.29732431 |
| 71 | MP0000678_abnormal_parathyroid_gland | 1.29388192 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.25317745 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.24992443 |
| 74 | MP0001915_intracranial_hemorrhage | 1.24424398 |
| 75 | MP0000858_altered_metastatic_potential | 1.23117281 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.21752674 |
| 77 | MP0008932_abnormal_embryonic_tissue | 1.21344013 |
| 78 | MP0002653_abnormal_ependyma_morphology | 1.18260209 |
| 79 | MP0002405_respiratory_system_inflammati | 1.17650580 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.16406960 |
| 81 | MP0000685_abnormal_immune_system | 1.15964518 |
| 82 | MP0001873_stomach_inflammation | 1.15728997 |
| 83 | MP0009785_altered_susceptibility_to | 1.14691700 |
| 84 | MP0002796_impaired_skin_barrier | 1.13975421 |
| 85 | MP0000703_abnormal_thymus_morphology | 1.12697608 |
| 86 | MP0004510_myositis | 1.09492166 |
| 87 | MP0005623_abnormal_meninges_morphology | 1.08404312 |
| 88 | MP0000313_abnormal_cell_death | 1.06798847 |
| 89 | MP0003724_increased_susceptibility_to | 1.05171307 |
| 90 | MP0003075_altered_response_to | 1.04850175 |
| 91 | MP0002398_abnormal_bone_marrow | 1.04690455 |
| 92 | MP0003115_abnormal_respiratory_system | 1.02529988 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.01316781 |
| 94 | MP0003091_abnormal_cell_migration | 1.01123230 |
| 95 | MP0002998_abnormal_bone_remodeling | 1.00352254 |
| 96 | MP0002722_abnormal_immune_system | 0.98984944 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.98798194 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 0.98660163 |
| 99 | MP0003329_amyloid_beta_deposits | 0.96336127 |
| 100 | MP0002925_abnormal_cardiovascular_devel | 0.95787394 |
| 101 | MP0000477_abnormal_intestine_morphology | 0.93888976 |
| 102 | MP0000681_abnormal_thyroid_gland | 0.91889921 |
| 103 | MP0009672_abnormal_birth_weight | 0.90706739 |
| 104 | MP0010630_abnormal_cardiac_muscle | 0.90029093 |
| 105 | MP0008469_abnormal_protein_level | 0.89816217 |
| 106 | MP0003119_abnormal_digestive_system | 0.89774456 |
| 107 | MP0005275_abnormal_skin_tensile | 0.89512261 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.89375496 |
| 109 | MP0009840_abnormal_foam_cell | 0.89282501 |
| 110 | MP0008770_decreased_survivor_rate | 0.88715712 |
| 111 | MP0000689_abnormal_spleen_morphology | 0.88360647 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.88258750 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.88192771 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.87912217 |
| 115 | MP0001958_emphysema | 0.87753813 |
| 116 | MP0003279_aneurysm | 0.87236758 |
| 117 | MP0004233_abnormal_muscle_weight | 0.86848808 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.86773376 |
| 119 | MP0000604_amyloidosis | 0.86182792 |
| 120 | MP0004272_abnormal_basement_membrane | 0.85725106 |
| 121 | MP0009931_abnormal_skin_appearance | 0.84584423 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.82529153 |
| 123 | MP0002111_abnormal_tail_morphology | 0.82268759 |
| 124 | MP0002092_abnormal_eye_morphology | 0.82213305 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.81889983 |
| 126 | MP0003448_altered_tumor_morphology | 0.81476501 |
| 127 | MP0005621_abnormal_cell_physiology | 0.81386570 |
| 128 | MP0001851_eye_inflammation | 0.81337214 |
| 129 | MP0005257_abnormal_intraocular_pressure | 0.81130071 |
| 130 | MP0006082_CNS_inflammation | 0.80555694 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.79392621 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.79137721 |
| 133 | MP0002429_abnormal_blood_cell | 0.78974249 |
| 134 | MP0000266_abnormal_heart_morphology | 0.77434590 |
| 135 | MP0005501_abnormal_skin_physiology | 0.77186153 |
| 136 | MP0004947_skin_inflammation | 0.76497920 |
| 137 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76293083 |
| 138 | MP0002697_abnormal_eye_size | 0.74330679 |
| 139 | MP0003283_abnormal_digestive_organ | 0.74259363 |
| 140 | MP0001216_abnormal_epidermal_layer | 0.72882871 |
| 141 | MP0003656_abnormal_erythrocyte_physiolo | 0.72553499 |
| 142 | MP0000343_altered_response_to | 0.72411945 |
| 143 | MP0002132_abnormal_respiratory_system | 0.72345512 |
| 144 | MP0009703_decreased_birth_body | 0.71670290 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.69771911 |
| 146 | MP0008058_abnormal_DNA_repair | 0.69546439 |
| 147 | MP0002932_abnormal_joint_morphology | 0.69495041 |
| 148 | MP0001614_abnormal_blood_vessel | 0.69050349 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.68098812 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.68094573 |
| 151 | MP0010155_abnormal_intestine_physiology | 0.67787220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.84834854 |
| 2 | Hyperacusis (HP:0010780) | 3.47926159 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.24053026 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.21482584 |
| 5 | Ependymoma (HP:0002888) | 3.17766206 |
| 6 | Ankle contracture (HP:0006466) | 3.03551416 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.03480103 |
| 8 | Selective tooth agenesis (HP:0001592) | 2.96820311 |
| 9 | Vertebral compression fractures (HP:0002953) | 2.95317237 |
| 10 | Distal lower limb amyotrophy (HP:0008944) | 2.89385733 |
| 11 | Shallow orbits (HP:0000586) | 2.82928945 |
| 12 | Increased IgE level (HP:0003212) | 2.76589914 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 2.72123535 |
| 14 | Abnormality of macrophages (HP:0004311) | 2.69412367 |
| 15 | Renal duplication (HP:0000075) | 2.67888502 |
| 16 | Ulnar bowing (HP:0003031) | 2.65628787 |
| 17 | Increased density of long bones (HP:0006392) | 2.64220350 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61584077 |
| 19 | Obstructive lung disease (HP:0006536) | 2.61584077 |
| 20 | Short 4th metacarpal (HP:0010044) | 2.61336646 |
| 21 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.61336646 |
| 22 | Rectal prolapse (HP:0002035) | 2.61170417 |
| 23 | Hemorrhage of the eye (HP:0011885) | 2.58485891 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.51942016 |
| 25 | Hypertensive crisis (HP:0100735) | 2.51751484 |
| 26 | Genu recurvatum (HP:0002816) | 2.48336352 |
| 27 | Abnormality of the astrocytes (HP:0100707) | 2.48010934 |
| 28 | Astrocytoma (HP:0009592) | 2.48010934 |
| 29 | Bladder diverticulum (HP:0000015) | 2.46994166 |
| 30 | Increased nuchal translucency (HP:0010880) | 2.42244450 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41910238 |
| 32 | Purpura (HP:0000979) | 2.41711203 |
| 33 | Bowel diverticulosis (HP:0005222) | 2.39790857 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.39275918 |
| 35 | Premature rupture of membranes (HP:0001788) | 2.37727982 |
| 36 | Renovascular hypertension (HP:0100817) | 2.37062639 |
| 37 | Basal cell carcinoma (HP:0002671) | 2.36998921 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 2.34745128 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.32556016 |
| 40 | High pitched voice (HP:0001620) | 2.30377314 |
| 41 | Insomnia (HP:0100785) | 2.29065957 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.28687251 |
| 43 | Cholecystitis (HP:0001082) | 2.28229465 |
| 44 | Abnormal gallbladder physiology (HP:0012438) | 2.28229465 |
| 45 | Mitral valve prolapse (HP:0001634) | 2.26936961 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.26803748 |
| 47 | Long palpebral fissure (HP:0000637) | 2.25024007 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.24694838 |
| 49 | Spastic diplegia (HP:0001264) | 2.23464417 |
| 50 | Abnormality of the calcaneus (HP:0008364) | 2.23059386 |
| 51 | Elfin facies (HP:0004428) | 2.22866935 |
| 52 | Abnormality of the 4th metacarpal (HP:0010012) | 2.21748678 |
| 53 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.21480778 |
| 54 | Recurrent viral infections (HP:0004429) | 2.19592251 |
| 55 | Broad face (HP:0000283) | 2.19512618 |
| 56 | Colitis (HP:0002583) | 2.19373706 |
| 57 | Reticulocytopenia (HP:0001896) | 2.18763049 |
| 58 | Colon cancer (HP:0003003) | 2.18710467 |
| 59 | Myopathic facies (HP:0002058) | 2.18131577 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.15435847 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.14623621 |
| 62 | Upper limb amyotrophy (HP:0009129) | 2.14623621 |
| 63 | Petechiae (HP:0000967) | 2.14279467 |
| 64 | Thrombocytosis (HP:0001894) | 2.14241867 |
| 65 | Hand muscle atrophy (HP:0009130) | 2.13790975 |
| 66 | Polygenic inheritance (HP:0010982) | 2.12727601 |
| 67 | Dilatation of the ascending aorta (HP:0005111) | 2.12156711 |
| 68 | Overriding aorta (HP:0002623) | 2.11056278 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.11041494 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11027668 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11027668 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11027668 |
| 73 | Thoracic kyphosis (HP:0002942) | 2.10994051 |
| 74 | Adenoma sebaceum (HP:0009720) | 2.09215605 |
| 75 | Angiofibromas (HP:0010615) | 2.09215605 |
| 76 | Aneurysm (HP:0002617) | 2.07904403 |
| 77 | Flat acetabular roof (HP:0003180) | 2.07838612 |
| 78 | Deviation of the thumb (HP:0009603) | 2.06647239 |
| 79 | Back pain (HP:0003418) | 2.06523959 |
| 80 | Abnormality of the peritoneum (HP:0002585) | 2.04599239 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.04323876 |
| 82 | Abnormality of the thoracic spine (HP:0100711) | 2.04029518 |
| 83 | Broad palm (HP:0001169) | 2.03792167 |
| 84 | Pseudobulbar signs (HP:0002200) | 2.03328802 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.03077348 |
| 86 | Broad distal phalanx of finger (HP:0009836) | 2.02302102 |
| 87 | Proximal placement of thumb (HP:0009623) | 2.02210572 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02191942 |
| 89 | Abnormal number of erythroid precursors (HP:0012131) | 2.00429901 |
| 90 | Hypertriglyceridemia (HP:0002155) | 1.99622500 |
| 91 | Meningitis (HP:0001287) | 1.99034193 |
| 92 | Hallux valgus (HP:0001822) | 1.98576716 |
| 93 | Lymphangioma (HP:0100764) | 1.98243343 |
| 94 | Gastrointestinal dysmotility (HP:0002579) | 1.97979127 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 1.96727765 |
| 96 | Deviation of the hallux (HP:0010051) | 1.96436384 |
| 97 | Radial bowing (HP:0002986) | 1.96061663 |
| 98 | Subacute progressive viral hepatitis (HP:0006572) | 1.95350755 |
| 99 | Aortic aneurysm (HP:0004942) | 1.95153991 |
| 100 | Fibroma (HP:0010614) | 1.92346108 |
| 101 | Bowed forearm bones (HP:0003956) | 1.91843212 |
| 102 | Bowing of the arm (HP:0006488) | 1.91843212 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 1.90949954 |
| 104 | Abnormality of reticulocytes (HP:0004312) | 1.90177320 |
| 105 | Inflammation of the large intestine (HP:0002037) | 1.90132983 |
| 106 | Medulloblastoma (HP:0002885) | 1.88180750 |
| 107 | Bicuspid aortic valve (HP:0001647) | 1.87130080 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.87111018 |
| 109 | Increased IgM level (HP:0003496) | 1.85935308 |
| 110 | Flattened epiphyses (HP:0003071) | 1.85779003 |
| 111 | Recurrent fungal infections (HP:0002841) | 1.85753746 |
| 112 | Increased connective tissue (HP:0009025) | 1.85334342 |
| 113 | Fibrous tissue neoplasm (HP:0012316) | 1.85225842 |
| 114 | Gastrointestinal carcinoma (HP:0002672) | 1.85006085 |
| 115 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.85006085 |
| 116 | Peritonitis (HP:0002586) | 1.83563091 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 1.83453665 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.82904529 |
| 119 | Cutaneous melanoma (HP:0012056) | 1.82813215 |
| 120 | Deep venous thrombosis (HP:0002625) | 1.82519163 |
| 121 | Increased serum ferritin (HP:0003281) | 1.82117680 |
| 122 | Emphysema (HP:0002097) | 1.81347637 |
| 123 | Missing ribs (HP:0000921) | 1.80609182 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 1.79829922 |
| 125 | Pointed chin (HP:0000307) | 1.79415961 |
| 126 | Myositis (HP:0100614) | 1.79334933 |
| 127 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78124426 |
| 128 | Thin bony cortex (HP:0002753) | 1.77041373 |
| 129 | Cervical subluxation (HP:0003308) | 1.76799075 |
| 130 | Fatigue (HP:0012378) | 1.76752984 |
| 131 | Gingivitis (HP:0000230) | 1.76562285 |
| 132 | Seborrheic dermatitis (HP:0001051) | 1.76341898 |
| 133 | Disproportionate tall stature (HP:0001519) | 1.75931992 |
| 134 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75872594 |
| 135 | Flat cornea (HP:0007720) | 1.75613835 |
| 136 | Progressive muscle weakness (HP:0003323) | 1.75404148 |
| 137 | Growth hormone excess (HP:0000845) | 1.74110012 |
| 138 | Reticulocytosis (HP:0001923) | 1.74097847 |
| 139 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73751440 |
| 140 | Loss of speech (HP:0002371) | 1.73327714 |
| 141 | Enlarged penis (HP:0000040) | 1.73101073 |
| 142 | Epistaxis (HP:0000421) | 1.72512897 |
| 143 | Wrist flexion contracture (HP:0001239) | 1.72226667 |
| 144 | Abnormality of the fingertips (HP:0001211) | 1.71756777 |
| 145 | Trismus (HP:0000211) | 1.71220629 |
| 146 | Easy fatigability (HP:0003388) | 1.71095482 |
| 147 | Neoplasm of striated muscle (HP:0009728) | 1.71027085 |
| 148 | Hyperparathyroidism (HP:0000843) | 1.70702951 |
| 149 | Hypergammaglobulinemia (HP:0010702) | 1.70354994 |
| 150 | Glioma (HP:0009733) | 1.70087598 |
| 151 | Difficulty climbing stairs (HP:0003551) | 1.69723415 |
| 152 | Bone pain (HP:0002653) | 1.69491282 |
| 153 | Aortic dissection (HP:0002647) | 1.69057781 |
| 154 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.68999759 |
| 155 | Heterotopia (HP:0002282) | 1.67798252 |
| 156 | Polycythemia (HP:0001901) | 1.67388517 |
| 157 | Lower limb amyotrophy (HP:0007210) | 1.67275339 |
| 158 | Neuronal loss in central nervous system (HP:0002529) | 1.67175760 |
| 159 | Skin tags (HP:0010609) | 1.66836718 |
| 160 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.66629946 |
| 161 | Slender long bone (HP:0003100) | 1.66030002 |
| 162 | Urticaria (HP:0001025) | 1.65226954 |
| 163 | Intestinal polyp (HP:0005266) | 1.65170499 |
| 164 | Granulocytopenia (HP:0001913) | 1.64495174 |
| 165 | Metaphyseal cupping (HP:0003021) | 1.64087652 |
| 166 | Rhabdomyosarcoma (HP:0002859) | 1.63309552 |
| 167 | Rough bone trabeculation (HP:0100670) | 1.62629565 |
| 168 | Nasal polyposis (HP:0100582) | 1.62474603 |
| 169 | Neoplasm of the pancreas (HP:0002894) | 1.62239954 |
| 170 | Increased mean platelet volume (HP:0011877) | 1.61035721 |
| 171 | Abnormal platelet volume (HP:0011876) | 1.60408571 |
| 172 | Megalocornea (HP:0000485) | 1.59871744 |
| 173 | Axonal loss (HP:0003447) | 1.59100682 |
| 174 | Elbow flexion contracture (HP:0002987) | 1.57610336 |
| 175 | Short 5th finger (HP:0009237) | 1.56926072 |
| 176 | Abnormality of oral frenula (HP:0000190) | 1.56877179 |
| 177 | Abnormal number of incisors (HP:0011064) | 1.56649248 |
| 178 | Bulbar palsy (HP:0001283) | 1.56067581 |
| 179 | Biliary tract neoplasm (HP:0100574) | 1.55957213 |
| 180 | Cellulitis (HP:0100658) | 1.55897353 |
| 181 | Broad metatarsal (HP:0001783) | 1.55782716 |
| 182 | Intestinal polyposis (HP:0200008) | 1.55387673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.58679324 |
| 2 | TRIB3 | 4.31285698 |
| 3 | PKN2 | 4.08158687 |
| 4 | MAP3K10 | 3.56166851 |
| 5 | SMG1 | 3.07998491 |
| 6 | PRPF4B | 2.72885108 |
| 7 | CDK12 | 2.54930714 |
| 8 | CDC7 | 2.51948388 |
| 9 | IRAK3 | 2.37016207 |
| 10 | NEK2 | 2.33101843 |
| 11 | SCYL2 | 2.01005746 |
| 12 | RPS6KB2 | 1.97510079 |
| 13 | LRRK2 | 1.85812391 |
| 14 | TTN | 1.82620351 |
| 15 | PAK4 | 1.70416584 |
| 16 | ERN1 | 1.70278373 |
| 17 | NEK1 | 1.70141575 |
| 18 | RPS6KA4 | 1.68583961 |
| 19 | PTK6 | 1.62463421 |
| 20 | MAP3K13 | 1.59263405 |
| 21 | STK10 | 1.56372661 |
| 22 | MAP4K1 | 1.55295479 |
| 23 | CDK4 | 1.53549077 |
| 24 | FLT3 | 1.50922888 |
| 25 | WEE1 | 1.50285475 |
| 26 | TAOK2 | 1.49721688 |
| 27 | PDGFRA | 1.46566873 |
| 28 | ARAF | 1.45294337 |
| 29 | TGFBR1 | 1.42086144 |
| 30 | VRK2 | 1.40331013 |
| 31 | ICK | 1.35848818 |
| 32 | MAP3K8 | 1.34828110 |
| 33 | PASK | 1.31535402 |
| 34 | RIPK1 | 1.29237585 |
| 35 | CDK6 | 1.26308155 |
| 36 | BUB1 | 1.26185881 |
| 37 | BMX | 1.24950902 |
| 38 | ALK | 1.18054963 |
| 39 | NME2 | 1.15501335 |
| 40 | TESK2 | 1.15356724 |
| 41 | RIPK4 | 1.15197975 |
| 42 | IRAK4 | 1.14471613 |
| 43 | MAP2K3 | 1.12149592 |
| 44 | TTK | 1.09744332 |
| 45 | CDK7 | 1.06718701 |
| 46 | SIK1 | 1.06582749 |
| 47 | MTOR | 1.05191260 |
| 48 | MAPKAPK3 | 1.05147628 |
| 49 | GRK6 | 1.04449165 |
| 50 | MAP3K14 | 1.03680305 |
| 51 | MAP3K1 | 0.99422523 |
| 52 | BCKDK | 0.98714169 |
| 53 | PAK2 | 0.96613147 |
| 54 | PRKD2 | 0.96403917 |
| 55 | EPHA2 | 0.95472579 |
| 56 | TAOK1 | 0.90425392 |
| 57 | MAP3K11 | 0.89281829 |
| 58 | ILK | 0.89132922 |
| 59 | LATS1 | 0.88219788 |
| 60 | AURKB | 0.86287882 |
| 61 | ACVR1B | 0.82535271 |
| 62 | PIM1 | 0.79885479 |
| 63 | ATR | 0.78459481 |
| 64 | STK4 | 0.78167645 |
| 65 | CDC42BPA | 0.76960668 |
| 66 | LMTK2 | 0.76874974 |
| 67 | LIMK1 | 0.76041631 |
| 68 | TSSK6 | 0.75930670 |
| 69 | DYRK3 | 0.74195918 |
| 70 | FGFR4 | 0.74106987 |
| 71 | PLK1 | 0.74006196 |
| 72 | TYRO3 | 0.73077736 |
| 73 | DDR2 | 0.71582472 |
| 74 | MARK2 | 0.71016493 |
| 75 | LATS2 | 0.70611190 |
| 76 | * CHEK1 | 0.68511312 |
| 77 | ZAP70 | 0.67455137 |
| 78 | BRAF | 0.67087392 |
| 79 | CSK | 0.64611289 |
| 80 | MOS | 0.63721421 |
| 81 | IKBKE | 0.63425355 |
| 82 | STK3 | 0.63276415 |
| 83 | IRAK2 | 0.63268335 |
| 84 | BLK | 0.62877006 |
| 85 | HIPK2 | 0.61535078 |
| 86 | RPS6KL1 | 0.61324384 |
| 87 | RPS6KC1 | 0.61324384 |
| 88 | MAPK11 | 0.59181914 |
| 89 | PTK2 | 0.58711820 |
| 90 | RPS6KA2 | 0.57395342 |
| 91 | RET | 0.57118900 |
| 92 | PDPK1 | 0.56885955 |
| 93 | BRSK1 | 0.56861332 |
| 94 | KDR | 0.56546023 |
| 95 | TYK2 | 0.56356044 |
| 96 | KSR2 | 0.56264429 |
| 97 | SIK3 | 0.55274542 |
| 98 | JAK3 | 0.54984376 |
| 99 | CSF1R | 0.53948908 |
| 100 | AKT2 | 0.53895151 |
| 101 | BTK | 0.53748080 |
| 102 | CHEK2 | 0.53518726 |
| 103 | * CDK2 | 0.52578757 |
| 104 | CAMK1D | 0.52212560 |
| 105 | TESK1 | 0.51919454 |
| 106 | DAPK1 | 0.50605150 |
| 107 | MAP3K7 | 0.49719220 |
| 108 | FGFR1 | 0.49652533 |
| 109 | FES | 0.49201007 |
| 110 | HCK | 0.49105820 |
| 111 | MATK | 0.49073148 |
| 112 | PDGFRB | 0.49012993 |
| 113 | MST1R | 0.48997097 |
| 114 | DYRK1B | 0.48624380 |
| 115 | SYK | 0.47070664 |
| 116 | MELK | 0.46714473 |
| 117 | PAK1 | 0.46527900 |
| 118 | CLK1 | 0.46477410 |
| 119 | CDK8 | 0.45750488 |
| 120 | CDK9 | 0.45412452 |
| 121 | RPS6KA1 | 0.44456557 |
| 122 | TGFBR2 | 0.43191975 |
| 123 | BRD4 | 0.42784310 |
| 124 | EIF2AK1 | 0.42596615 |
| 125 | ABL2 | 0.41940649 |
| 126 | EPHB1 | 0.41667388 |
| 127 | AURKA | 0.41284530 |
| 128 | TBK1 | 0.40508561 |
| 129 | ATM | 0.40243185 |
| 130 | FGR | 0.39964538 |
| 131 | SIK2 | 0.39720431 |
| 132 | PRKD3 | 0.39617155 |
| 133 | IKBKB | 0.39324262 |
| 134 | RPS6KA6 | 0.39254829 |
| 135 | CDK11A | 0.39011270 |
| 136 | LCK | 0.38555914 |
| 137 | MAP3K3 | 0.34657684 |
| 138 | MAP2K2 | 0.34644294 |
| 139 | DMPK | 0.33586068 |
| 140 | BRSK2 | 0.32956071 |
| 141 | MAPKAPK2 | 0.31430072 |
| 142 | PIM2 | 0.29258265 |
| 143 | ITK | 0.28508031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.73543757 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72901472 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.71907413 |
| 4 | Spliceosome_Homo sapiens_hsa03040 | 2.36248486 |
| 5 | Cell cycle_Homo sapiens_hsa04110 | 2.34938577 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.30998354 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.18321784 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.16093314 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.10663752 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.96938221 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.93668186 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.80324324 |
| 13 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.70558015 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.69889871 |
| 15 | Bladder cancer_Homo sapiens_hsa05219 | 1.58092968 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.52542008 |
| 17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.49869738 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49423066 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48161858 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46685994 |
| 21 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.46022938 |
| 22 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.45737115 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37639689 |
| 24 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.37393643 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.36020335 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.32659944 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.31485364 |
| 28 | HTLV-I infection_Homo sapiens_hsa05166 | 1.29258540 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27903882 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.27758643 |
| 31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.27247326 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26281250 |
| 33 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24186695 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24018162 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23877046 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23606164 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23066318 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19336636 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.17879949 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17007569 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.16099156 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.13529960 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12248557 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.10051264 |
| 45 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.07799506 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 1.06465340 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.06355246 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.06057996 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.05911247 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.05116335 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.04242576 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 1.03699200 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 1.02086986 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01479952 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.98572263 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97092930 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.96626130 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.96595679 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96507021 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96306619 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95314109 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95267207 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94473148 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93900815 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93514185 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93459130 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92220660 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.91725919 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91010181 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90700299 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89898572 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89393981 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.89319623 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.88840715 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87375115 |
| 76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87314868 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87246884 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86017956 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85345722 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85203180 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84785478 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83881505 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83271846 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81942715 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81347774 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81186000 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81135790 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80563027 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80278305 |
| 90 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.79033299 |
| 91 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78250423 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77441193 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77402121 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.75726292 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.75397176 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75233677 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74671739 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73705516 |
| 99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73592552 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73508926 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71739758 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70172216 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.70074914 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.69956348 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68915214 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.68043301 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.67103170 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.66405229 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.65006223 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.63736134 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63010952 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.62471028 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.62312997 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61918167 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61643535 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60409855 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.60091660 |
| 118 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59631706 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58313026 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58256789 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57310301 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56462823 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56248780 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56120350 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56048653 |
| 126 | Asthma_Homo sapiens_hsa05310 | 0.55904292 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54357495 |
| 128 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53891110 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53689291 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53664130 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51824142 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50716666 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50258703 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49898725 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46535953 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46017077 |
| 137 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45968295 |

